Christopher Jewell
Förmögenhet: 1 M $ per 2026-06-30
Förmögenhet: 1 M $ per 2026-06-30
Christopher Jewell worked as a Professor at the University of Maryland from 2020 to 2024.
Dr. Jewell served as Chief Scientific Officer at Cartesian Therapeutics, Inc. (United States) in 2023 and continued in the same role at Cartesian Therapeutics, Inc. from 2023 to 2025.
Dr. Jewell earned a doctorate from the University of Wisconsin.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
0,36 % | 2026-04-14 | 104 877 ( 0,36 % ) | 1 M $ | 2026-06-30 |
| Företag | Position | Slut |
|---|---|---|
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | 2024-04-01 |
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage company that develops mRNA cell therapies for autoimmune diseases | Teknisk/Vetenskaplig/F&U Direktör | 2023-11-13 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage company that develops mRNA cell therapies for autoimmune diseases | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån